New hope for Tough-to-Treat lung cancer: can this combo extend life?
Disease control
Not yet recruiting
This global study is testing whether adding an experimental drug called plinabulin to standard chemotherapy (docetaxel) helps people with advanced non-small cell lung cancer live longer. It's for patients whose cancer has worsened after trying immunotherapy and platinum-based che…
Phase: PHASE3 • Sponsor: BeyondSpring Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:46 UTC